BRIGHTON JONES LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
BRIGHTON JONES LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$222,251
-18.3%
40,780
+0.5%
0.01%
-21.4%
Q2 2023$272,138
-23.0%
40,557
+1.4%
0.01%
-30.0%
Q1 2023$353,324
+79.6%
40,014
+55.4%
0.02%
+66.7%
Q4 2022$196,738
-18.4%
25,751
-23.9%
0.01%
-14.3%
Q3 2022$241,000
-10.7%
33,858
+1.5%
0.01%
-12.5%
Q2 2022$270,000
-41.0%
33,354
+1.1%
0.02%
-23.8%
Q1 2022$458,000
-56.1%
33,002
-11.3%
0.02%
-57.1%
Q4 2021$1,044,000
-32.0%
37,197
-17.6%
0.05%
-38.0%
Q3 2021$1,535,000
-16.8%
45,169
+0.1%
0.08%
-16.8%
Q2 2021$1,845,000
+0.8%
45,142
-0.7%
0.10%
-12.0%
Q1 2021$1,830,000
-34.1%
45,447
-3.2%
0.11%
-36.8%
Q4 2020$2,775,000
+21.6%
46,9320.0%0.17%
+8.2%
Q3 2020$2,282,000
+1.4%
46,932
+0.8%
0.16%
-13.7%
Q2 2020$2,251,000
+50.2%
46,537
-13.7%
0.18%
+15.8%
Q1 2020$1,499,00053,9460.16%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders